Skip to content

US Authorizes Pfizer Vaccine for Children Ages 5 to 11

The director of the Centers for Disease Control and Prevention (CDC, in English) of the United States, Rochelle Walensky, authorized this Tuesday that the vaccine against the COVID-19 Pfizer / BioNTech is given to minors between the ages of 5 and 11.

SIGHT: COVID-19 | US Scientific Committee Recommends Pfizer Vaccine for Children Ages 5-11

Tuesday’s decision will allow this age group, made up of about 28 million children, to start, according to the CDC.

”As a mother, I encourage parents with questions to speak with their pediatrician, school nurse, or local pharmacist to learn more about the vaccine and the Walensky stated.

SIGHT: COVID-19 | About alcohol in shoes and other little or no effective care in this pandemic

For his part, US President Joe Biden assured that vaccination from 5 to 11 years “It will allow parents to end months of worrying about their children and reduce the degree to which childrento other people”.

Walensky’s decision came hours after a CDC panel of experts recommended the measure.

SIGHT: COVID-19 | What is known about possible hair loss after infection and the vaccine?

At that meeting, the CDC director stressed that during the recent wave of the Delta variant, they have skyrocketed in hospitals in the United States.

According to data from the CDC, since the beginning of the pandemic, 1.9 million cases of COVID-19 have been registered among children between 5 and 11 years old, 8,300 hospitalizations and 94 deaths.

Added to them are 2,316 cases of children of those ages that, which involves inflammation of various organs and is a complication derived from COVID-19.

Before proceeding to the vote, several ACIP members mentioned the impact the pandemic has had on minors.

”Too many children have lost a parent or orphaned in this pandemic, which is incredibly tragic, so as an infectious disease specialist and mother with two vaccinated children, said physician Camille Kotton.

The Pfizer / BioNTech vaccine for children between 5 and 11 years old – which will be 10 milligrams, a third of the serum of adults – will not be administered in large immunization centers, but in pediatric clinics and pharmacies.

The US Government reported this week that it had already secured sufficient doses of the serum for the 28 million children between those ages, so starting next week the.

  • COVID-19 | US Scientific Committee Recommends Pfizer Vaccine for Children Ages 5-11
  • COVID-19 | About alcohol in shoes and other little or no effective care in this pandemic
  • COVID-19 | What is known about possible hair loss after infection and the vaccine?
  • COVID-19 | How do patients who lost it to the coronavirus regain their sense of smell?
  • COVID-19 | How effective is the third dose of Pfizer against the Delta variant?
  • “Vax” is the word of the year in English, according to the Oxford Dictionary
  • The utopia of COVID-19 zero, by Elmer Huerta
  • COVID-19 | EMA Says “There is Not Sufficient Evidence” Vaccines Cause Multisystem Inflammatory Syndrome
  • COVID-19 | Vaccines protect against the Delta variant, but do not stop contagion within the home
  • Sotrovimab antibody reduces risk of hospitalization or death from COVID-19 by 79%
  • Fluvoxamine Drug Reduces COVID-19 Hospitalizations, Study Finds
  • People with a history of cancer are at increased risk of complications from COVID-19
  • Why do some healthy young people get severe COVID-19?
  • COVID-19 | Merck announces that a generic version of its pill would be distributed in poor countries
  • The world has not learned from the COVID-19 pandemic, warn WHO and World Bank
  • COVID-19 | Halving the first dose of AstraZeneca improves its potency, study finds
  • More than 80% of COVID-19 patients are at risk of malnutrition when leaving the hospital
  • What does the WHO say about the end of the COVID-19 pandemic?
  • COVID-19 | Scientists discover a method to block coronavirus infection
  • European Medicines Agency Launches Accelerated Review of Merck’s COVID-19 Pill
  • Moderna announces that its vaccine has strong efficacy in children aged 6 to 11 years
  • The Answers for a Safe Return to School, by Elmer Huerta
  • COVID-19 | Everything you need to know about the effects of vaccines
  • Face-to-face classes at universities: what measures should be taken to avoid contagion?

Follow us on twitter:


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);

.

Share this article:
globalhappenings news.jpg
most popular